Teza Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $485K | Buy |
923
+527
| +133% | +$277K | 0.36% | 90 |
|
|
2025
Q1 | $251K | Sell |
396
-898
| -69% | -$570K | 0.11% | 306 |
|
|
2024
Q4 | $922K | Buy |
1,294
+429
| +50% | +$306K | 0.14% | 196 |
|
|
2024
Q3 | $909K | Buy |
+865
| New | +$909K | 0.1% | 268 |
|
|
2024
Q1 | – | Sell |
-1,643
| Closed | -$1.44M | – | 718 |
|
|
2023
Q4 | $1.44M | Buy |
+1,643
| New | +$1.44M | 0.24% | 132 |
|
|
2023
Q3 | – | Sell |
-359
| Closed | -$258K | – | 737 |
|
|
2023
Q2 | $258K | Buy |
+359
| New | +$258K | 0.04% | 439 |
|
|
2022
Q3 | – | Sell |
-351
| Closed | -$207K | – | 612 |
|
|
2022
Q2 | $207K | Buy |
+351
| New | +$207K | 0.08% | 387 |
|
|
2022
Q1 | – | Sell |
-1,529
| Closed | -$966K | – | 514 |
|
|
2021
Q4 | $966K | Buy |
1,529
+998
| +188% | +$631K | 0.26% | 119 |
|
|
2021
Q3 | $321K | Sell |
531
-4,685
| -90% | -$2.83M | 0.15% | 202 |
|
|
2021
Q2 | $2.91M | Buy |
+5,216
| New | +$2.91M | 0.47% | 54 |
|
|
2020
Q3 | – | Sell |
-1,558
| Closed | -$972K | – | 563 |
|
|
2020
Q2 | $972K | Buy |
+1,558
| New | +$972K | 0.22% | 139 |
|
|
2020
Q1 | – | Sell |
-2,809
| Closed | -$1.06M | – | 429 |
|
|
2019
Q4 | $1.06M | Buy |
2,809
+1,729
| +160% | +$649K | 0.29% | 85 |
|
|
2019
Q3 | $300K | Buy |
+1,080
| New | +$300K | 0.08% | 377 |
|
|
2018
Q1 | – | Sell |
-905
| Closed | -$340K | – | 483 |
|
|
2017
Q4 | $340K | Buy |
+905
| New | +$340K | 0.2% | 210 |
|